|
32853584 |
0 |
Arnold DM, Heddle NM, Cook RJ, et al.
Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial.
Lancet Haematol. 2020 Sep;7(9):e640-e648. doi: 10.1016/S2352-3026(20)30227-1.
|
|
31899848 |
0 |
Galanaud JP, Righini M, Le Collen L, et al.
Long-term risk of postthrombotic syndrome after symptomatic distal deep vein thrombosis: The CACTUS-PTS study.
J Thromb Haemost. 2020 Apr;18(4):857-864. doi: 10.1111/jth.14728. Epub 2020 Feb 11.
|
|
31380891 |
0 |
Douketis JD, Spyropoulos AC, Duncan J, et al.
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant.
JAMA Intern Med. 2019 Nov 1;179(11):1469-1478. doi: 10.1001/jamainternmed.2019.2431.
|
|
30685874 |
0 |
Arnold DM, Jamula E, Heddle NM, et al.
Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale.
Thromb Haemost. 2019 Mar;119(3):500-507. doi: 10.1055/s-0038-1677531. Epub 2019 Jan 27.
|
|
30113416 |
0 |
Aguilar C, Sartori M, D'Angelo A, et al.
Validation of the STA-Liatest DDi assay for exclusion of proximal deep vein thrombosis according to the latest Clinical and Laboratory Standards Institute/Food and Drug Administration guideline: results of a multicenter management study.
Blood Coagul Fibrinolysis. 2018 Sep;29(6):562-566. doi: 10.1097/MBC.0000000000000750.
|
|
29542828 |
0 |
Perreault S, Shahabi P, Cote R, et al.
Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study.
Clin Cardiol. 2018 May;41(5):576-585. doi: 10.1002/clc.22948. Epub 2018 May 15.
|
|
29212129 |
0 |
Douketis JD, Spyropoulos AC, Anderson JM, et al.
The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale.
Thromb Haemost. 2017 Dec;117(12):2415-2424. doi: 10.1160/TH17-08-0553. Epub 2017 Dec 6.
|
|
27428016 |
0 |
Pernod G, Wu H, de Maistre E, et al.
Validation of STA-Liatest D-Di assay for exclusion of pulmonary embolism according to the latest Clinical and Laboratory Standard Institute/Food and Drug Administration guideline. Results of a multicenter management study.
Blood Coagul Fibrinolysis. 2017 Apr;28(3):254-260. doi: 10.1097/MBC.0000000000000591.
|